Publications récentes:

Schweizer N, T Viereckel, C Smith-Anttila, K Nordenankar, E Arvisson, S Mahmoudi, A Zampera, H Warner Jonsson, J Bergquist, D Lévesque, A Konradsson-Geuken, M Andersson, S Dumas and A Wallen-Mackenzie, Reduced sugar consumption and altered size of subtalamic nucleus identify a role for Pitx2/Vglut2 co-expressing neurons in action selection, eNeuro, 3(5) e0264-16, 2016.

Fakhoury M, D Voyer, D Lévesque and PP Rompré, Effect of electrolytic lesions of the dorsal diencephalic conduction system on the distribution of Fos-like immunoreactivity induced by rewarding electrical stimulation, Neuroscience, 334: 214-225, 2016.

Voyer D, Lévesque D and PP Rompré, Repeated ventral midbrain neurotensin injections sensitize to amphetamine-induced locomotion and ERK activation: a role for NMDA receptors, Neuropharmacology, 112: 150-163, 2016.

Giner X, D Cotnoir-White, S Mader and D. Lévesque, Selective ligand activity at Nur/retinoid X receptor complexes revealed by dimer-specific bioluminescence resonance energy transfer-based sensors, FASEB J, 29: 4256-4267 2015.

Hernandez G, A Khodami-Pour, D Lévesque and PP Rompré, Reduction in ventral midbrain NMDA receptors reveals two opposite modulatory roles for glutamate on reward, Neuropsychopharmacology, 40: 1682-1691, 2015.

Rocchetti J, Isingrini E, Dal Bo G, Sagheby S, Menagaux A, Tronche F, Lévesque D, Moquin L, Gratton A, Wong TP, Rubinstein M and Giros B, Presynaptic D₂ dopamine receptors control LTD expression and memory processes in the temporal hippocampus, Biol. Psychiatry, 77: 513-525, 2015.

Mahmoudi S, Lévesque D and Blanchet PJ, Upregulation of dopamine D₃, but not D₂, receptors correlates with tardive dyskinesia in primate model, Mov. Disorders, 29: 1125-1133, 2014. This paper was highlighted in the journal’s editorial section, Jenner P, A late appearance by the dopamine D-3 receptor, Mov. Disorders, 29: 1094-1096, 2014.

Schweizer N, Pupe S, Arvidsson E, Nordenankar K, Smith-Anttila CJA, Mahmoudi S, Andren A, Dumas S, Rajagopalan A, Lévesque D, Leao RN and Wallen-Mackenzie A, Limiting glutamatergic transmission in a Vglut2-expressing subpopulation of the subtalamic nucleus is sufficient to cause hyperlocomotion, Proc. Natl. Acad. Sci. USA, 111: 7837-7842, 2014.

Bouayad-Gervais K, Minogianis EA, Lévesque D and Samaha AN, The self administration of rapidly delivered cocaine promotes increased motivation to take the drug: contributions of prior levels of operant responding and cocaine intake, Psychopharmacology (Berlin), 231: 4241-4252, 2014.

Mahmoudi S, PJ Blanchet and D Lévesque, Haloperidol-induced Nur77 expression in non-human primate model is associated with tardive dyskinesia, Eur. J. Neurosci., 38: 2192-2198, 2013.

Minogianis EA, D Lévesque and AN Samaha, The speed of cocaine delivery determines the subsequent motivation to self-administer the drug, Neuropsychopharmacology, 38: 2644-2656, 2013.

Bédard AM, J Maheux, D Lévesque and AN Samaha, Prior haloperidol, but not olanzapine, exposure augments the pursuit of reward cues: implications for substance abuse in schizophrenia, Schizophrenia Bull., 39: 692-702, 2013.

Samadi P, Boutet A, Rymar V, Rewal K, Maheux J, Chakrya-Kvann J, Tomaszewski M, Beaubien F, Cloutier JF, Lévesque D and Sadikot A, Relationship between BDNF expression in major striatal afferents, striatum morphology and motor behavior in the R6/2 mouse model of Huntington’s disease, Genes, Brain and Behav., 12: 108-124, 2013.